loadpatents
Patent applications and USPTO patent grants for SCHANZER; Juergen Michael.The latest application filed is for "protease-activated t cell bispecific molecules".
Patent | Date |
---|---|
Protease-activated T Cell Bispecific Molecules App 20220275087 - BRUENKER; Peter ;   et al. | 2022-09-01 |
Protease-activated T cell bispecific molecules Grant 11,242,390 - Bruenker , et al. February 8, 2 | 2022-02-08 |
Activatable Bispecific Antibodies App 20220017640 - BRINKMANN; Ulrich ;   et al. | 2022-01-20 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20210047394 - Baehner; Monika ;   et al. | 2021-02-18 |
Bispecific Antigen Binding Proteins App 20200369758 - IMHOF-JUNG; Sabine ;   et al. | 2020-11-26 |
Bispecific Her2 Antibodies And Methods Of Use App 20200291131 - Croasdale-Wood; Rebecca ;   et al. | 2020-09-17 |
Bispecific antigen binding proteins Grant 10,640,555 - Imhof-Jung , et al. | 2020-05-05 |
Bispecific HER2 antibodies and methods of use Grant 10,584,178 - Croasdale-Wood , et al. | 2020-03-10 |
Trivalent, Bispecific Antibodies App 20200062826 - BRINKMANN; Ulrich ;   et al. | 2020-02-27 |
Protease-activated T Cell Bispecific Molecules App 20190119383 - BRUENKER; Peter ;   et al. | 2019-04-25 |
Bispecific antibodies Grant 10,106,600 - Brinkmann , et al. October 23, 2 | 2018-10-23 |
Trivalent, Bispecific Antibodies App 20180282399 - BRINKMANN; Ulrich ;   et al. | 2018-10-04 |
Bispecific Antigen Binding Proteins App 20180079805 - IMHOF-JUNG; Sabine ;   et al. | 2018-03-22 |
Trivalent, bispecific antibodies Grant 9,890,204 - Brinkmann , et al. February 13, 2 | 2018-02-13 |
Bispecific antibodies comprising a disulfide stabilized-Fv fragment Grant 9,879,095 - Brinkmann , et al. January 30, 2 | 2018-01-30 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20170369566 - Baehner; Monika ;   et al. | 2017-12-28 |
Bispecific, Bivalent Anti-vegf/anti-ang-2 Antibodies App 20170240626 - Baehner; Monika ;   et al. | 2017-08-24 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 9,708,396 - Baehner , et al. July 18, 2 | 2017-07-18 |
Bispecific antigen binding proteins Grant 9,676,845 - Imhof-Jung , et al. June 13, 2 | 2017-06-13 |
Bispecific anti-EGFR/anti IGF-1R antibodies Grant 9,650,442 - Hosse , et al. May 16, 2 | 2017-05-16 |
Bispecific Her2 Antibodies And Methods Of Use App 20170029529 - Croasdale; Rebecca ;   et al. | 2017-02-02 |
Multispecific antibodies comprising full length antibodies and single chain fab fragments Grant 9,382,323 - Brinkmann , et al. July 5, 2 | 2016-07-05 |
Bispecific, Bivalent Anti-vegf/anti-ang2 Antibodies App 20150191535 - Baehner; Monika ;   et al. | 2015-07-09 |
Bispecific, Tetravalent Antigen Binding Proteins App 20150044214 - IMHOF-JUNG; Sabine ;   et al. | 2015-02-12 |
Tri- Or Tetraspecific Antibodies App 20150030598 - CROASDALE; Rebecca ;   et al. | 2015-01-29 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20150004166 - Baehner; Monika ;   et al. | 2015-01-01 |
Tri- or tetraspecific antibodies Grant 8,796,424 - Croasdale , et al. August 5, 2 | 2014-08-05 |
Bispecific Anti-egfr/anti Igf-1r Antibodies App 20140193415 - Hosse; Ralf ;   et al. | 2014-07-10 |
Bispecific Anti ErbB3 / Anti cMet Antibodies App 20140135482 - Bossenmaier; Birgit ;   et al. | 2014-05-15 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 8,703,130 - Baehner , et al. April 22, 2 | 2014-04-22 |
Bispecific, tetravalent antigen binding proteins Grant 8,703,132 - Imhof-Jung , et al. April 22, 2 | 2014-04-22 |
Bispecific Anti ErbB2/Anti cMet Antibodies App 20130273054 - Bossenmaier; Birgit ;   et al. | 2013-10-17 |
Activatable Bispecific Antibodies App 20130266568 - BRINKMANN; ULRICH ;   et al. | 2013-10-10 |
Bispecific Antibodies Comprising A Disulfide Stabilized - Fv Fragment App 20130267686 - BRINKMANN; ULRICH ;   et al. | 2013-10-10 |
Bispecific Anti ErbB1 / Anti cMet Antibodies App 20130156772 - Bossenmaier; Birgit ;   et al. | 2013-06-20 |
Trivalent, Bispecific Antibodies App 20130022601 - Brinkmann; Ulrich ;   et al. | 2013-01-24 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20120321627 - Baehner; Monika ;   et al. | 2012-12-20 |
Bispecific anti-VEGF/anti-ANG-2 antibodies Grant 8,268,314 - Baehner , et al. September 18, 2 | 2012-09-18 |
Bispecific Antibodies App 20110293613 - BRINKMANN; ULRICH ;   et al. | 2011-12-01 |
Bispecific, Bivalent Anti-vegf/anti-ang-2 Antibodies App 20110236388 - Baehner; Monika ;   et al. | 2011-09-29 |
Bispecific, Tetravalent Antigen Binding Proteins App 20100322934 - Imhof-Jung; Sabine ;   et al. | 2010-12-23 |
Tri- or Tetraspecific Antibodies App 20100322935 - CROASDALE; REBECCA ;   et al. | 2010-12-23 |
Bispecific Antigen Binding Proteins App 20100316645 - Imhof-Jung; Sabine ;   et al. | 2010-12-16 |
Bispecific Anti ErbB1 / Anti c Met Antibodies App 20100254989 - Bossenmaier; Birgit ;   et al. | 2010-10-07 |
Bispecific Anti ErbB2 / Anti cMet Antibodies App 20100254988 - Bossenmaier; Birgit ;   et al. | 2010-10-07 |
Bispecific Anti ErbB3 / Anti cMet Antibodies App 20100256339 - Bossenmaier; Birgit ;   et al. | 2010-10-07 |
Trivalent, Bispecific Antibodies App 20100256340 - Brinkmann; Ulrich ;   et al. | 2010-10-07 |
Multispecific Antibodies Comprising Full Length Antibodies And Single Chain Fab Fragments App 20100256338 - Brinkmann; Ulrich ;   et al. | 2010-10-07 |
Bispecific Anti-vegf/anti-ang-2 Antibodies App 20100111967 - Baehner; Monika ;   et al. | 2010-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.